244 related articles for article (PubMed ID: 8750395)
1. Angiotensin II receptor antagonism: losartan - sites and mechanisms of action.
Triggle DJ
Clin Ther; 1995; 17(6):1005-30. PubMed ID: 8750395
[TBL] [Abstract][Full Text] [Related]
2. [Angiotensin-II receptor blockers].
Metelitsa VI
Ter Arkh; 1996; 68(8):64-7. PubMed ID: 9019837
[No Abstract] [Full Text] [Related]
3. Angiotensin II receptor antagonists: the prototype losartan.
Schaefer KL; Porter JA
Ann Pharmacother; 1996 Jun; 30(6):625-36. PubMed ID: 8792950
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor inhibition. A new therapeutic principle.
Messerli FH; Weber MA; Brunner HR
Arch Intern Med; 1996 Sep; 156(17):1957-65. PubMed ID: 8823149
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptors and angiotensin II receptor antagonists.
Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD
Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104
[No Abstract] [Full Text] [Related]
6. Losartan for hypertension.
Med Lett Drugs Ther; 1995 Jun; 37(951):57-8. PubMed ID: 7783693
[No Abstract] [Full Text] [Related]
7. [Losartan].
Pfaffendorf M
Dtsch Med Wochenschr; 1996 Sep; 121(36):1101-2. PubMed ID: 8846756
[No Abstract] [Full Text] [Related]
8. The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonist.
Duncia JV; Carini DJ; Chiu AT; Johnson AL; Price WA; Wong PC; Wexler RR; Timmermans PB
Med Res Rev; 1992 Mar; 12(2):149-91. PubMed ID: 1619965
[No Abstract] [Full Text] [Related]
9. Losartan: the first angiotensin receptor antagonist in clinical use.
Beevers DG
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S1. PubMed ID: 8583475
[No Abstract] [Full Text] [Related]
10. A new class of antihypertensive therapy: angiotensin II receptor antagonists.
Ellis ML; Patterson JH
Pharmacotherapy; 1996; 16(5):849-60. PubMed ID: 8888079
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II receptor blockers. A new class of antihypertensive drugs.
Velasquez MT
Arch Fam Med; 1996 Jun; 5(6):351-6. PubMed ID: 8640326
[TBL] [Abstract][Full Text] [Related]
12. Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension.
Goa KL; Wagstaff AJ
Drugs; 1996 May; 51(5):820-45. PubMed ID: 8861549
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin receptor antagonists: focus on losartan.
Johnston CI
Lancet; 1995 Nov; 346(8987):1403-7. PubMed ID: 7475826
[No Abstract] [Full Text] [Related]
14. [Angiotensin II antagonists: a distinct therapeutic class].
Waeber B; Brunner HR
Presse Med; 1996 Oct; 25(32):1533-5. PubMed ID: 8952659
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.
Schmidt B; Schieffer B
J Med Chem; 2003 Jun; 46(12):2261-70. PubMed ID: 12773029
[No Abstract] [Full Text] [Related]
16. Discovery of losartan, the first angiotensin II receptor antagonist.
Timmermans PB; Duncia JV; Carini DJ; Chiu AT; Wong PC; Wexler RR; Smith RD
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S3-18. PubMed ID: 8583479
[TBL] [Abstract][Full Text] [Related]
17. The diversified pharmacology of angiotensin II-receptor blockade.
Timmermans PB; Smith RD
Blood Press Suppl; 1996; 2():53-61. PubMed ID: 8913541
[TBL] [Abstract][Full Text] [Related]
18. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
Dahlöf B
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
[TBL] [Abstract][Full Text] [Related]
19. The advantages of angiotensin II antagonism.
Burnier M; Waeber B; Brunner HR
J Hypertens Suppl; 1994 Jul; 12(2):S7-15. PubMed ID: 7965267
[TBL] [Abstract][Full Text] [Related]
20. [The medicine of the month. Losartan (Cozaar)].
Scheen AJ
Rev Med Liege; 1997 May; 52(5):367-9. PubMed ID: 9273640
[No Abstract] [Full Text] [Related]
[Next] [New Search]
